ClinicalTrials.Veeva

Menu

Staphylococcus Aureus Bacteraemia (SAB)-Support-Study (SABOT)

U

University Medicine Greifswald

Status

Completed

Conditions

Staphylococcus Aureus Bacteremia

Treatments

Other: Checklist-based phone calls

Study type

Interventional

Funder types

Other

Identifiers

NCT06249451
BB 140/23

Details and patient eligibility

About

The main objective of this study is to investigate whether checklist-based close telephone consultation and process surveillance for S. aureus bacteraemia (SAB) can improve adherence to our in-house SAB-guidelines (prospective quality- improvement group).

In addition, the effects of telephone consultation on the clinical outcome of patients will be examined.

Enrollment

124 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥ 18 years
  • Inpatient treatment at the University Medicine Greifswald university hospital
  • First diagnosis of SAB in hospital

Exclusion criteria

  • SAB already known before admission
  • Palliative management within 48 hrs after SAB diagnosis
  • Death within 48 hrs after SAB diagnosis
  • Hospital discharge within 48hrs after SAB diagnosis

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

124 participants in 2 patient groups

Retrospective control group (n= 62)
No Intervention group
Description:
Analysis of patients with the diagnosis of S. aureus-bacteraemia between 01.10.2022-01.10.2023
Prospective quality-improvement group (n= 62)
Other group
Description:
Analysis of patients with the diagnosis of S. aureus-bacteraemia between 22.01.2024-22.01.2025
Treatment:
Other: Checklist-based phone calls

Trial contacts and locations

1

Loading...

Central trial contact

Lena Ulm

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems